Chemours, DuPont and Corteva will pay $455 million over 15 years to resolve North Carolina PFAS-related claims, clarifying long-term liabilities.
Rhea-AI Summary
Chemours (CC), together with DuPont and Corteva, has agreed to a $455 million settlement with North Carolina and 11 local entities to resolve PFAS-related litigations and other historical discharge claims tied to the Fayetteville Works facility and alleged PFAS contamination unrelated to that site.
The settlement will be paid over 15 years, beginning within 30 days of execution. Chemours will bear 50% of the payments under a 2021 MOU, with its share estimated at about $180 million on a net present value basis and around $50 million expected over the next 12 months. Of the total, $18 million relates to alleged PFAS contamination outside Fayetteville Works, including AFFF use. Existing accruals are expected to cover Chemours' share. The agreement also satisfies all future contributions to the MOU escrow, including a $50 million payment previously due in September 2026, and credits roughly $210 million of qualified spend under the MOU.
Positive
- $455 million settlement over 15 years provides long-term liability clarity for PFAS-related claims
- Chemours’ 50% share (about $180 million NPV) is covered by existing accruals
- ~$50 million Chemours payment expected in next 12 months limits near-term cash outflow
- All future MOU escrow contributions, including Chemours’ planned $50 million in September 2026, are now considered satisfied
- Settlement counted as about $210 million of qualified spend under the Chemours-DuPont-Corteva MOU
Negative
- Total PFAS-related settlement obligates parties to $455 million in payments over 15 years
- Chemours faces cash payments of about $50 million over the next 12 months under the settlement
News Explained
The settlement framework is in place, but dismissals and certain off-site obligations remain unresolved.
Chemours has entered into the settlement, but it remains subject to entry of dismissals in the covered litigations; the agreement also creates procedures for remaining off-site obligations, including drinking-water programs.
The practical change is therefore a documented settlement framework rather than a statement that every related claim and obligation has been completed.
The next specific milestones are entry of the dismissals and implementation of the remaining off-site obligations described in the settlement.
Key Figures
- Settlement amount
- $455 million
- Paid over 15 years
- Chemours share
- 50% / approximately $180 million
- Net present value basis; covered by existing accruals
- Next-twelve-month payments
- Approximately $50 million
- Chemours expected share
- Unrelated contamination allocation
- $18 million
- PFAS contamination unrelated to Fayetteville Works
- Payment commencement
- Within 30 days
- Beginning after execution of the agreement
- Qualified spend valuation
- Approximately $210 million
- Settlement amount for MOU qualified-spend calculations
- Escrow contribution
- $50 million
- Chemours contribution due in September 2026 considered satisfied
Historical Context
-
Legal and environmental reserves tied to settlements contributed to the reported net loss.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
pfas technical
aqueous film forming foam ("AFFF") technical
net present value financial
consent order regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Resolves litigations brought by the State of North Carolinaand 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of aqueous film forming foam ("AFFF").
- Overall settlement payments total over 15 years; Chemours'$455 million50%share of payments of approximatelyon a net present value basis, which are covered by existing accruals.$180 million
- The settlement recognizes the significant investments and progress made under the 2019 Consent Order with the State of North Carolina, including substantial reductions in PFAS emissions from Fayetteville Works and mitigation of off-site impacts in the surrounding communities.
The Settlement resolves litigations brought by the State and the settling local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contamination unrelated to that site, including from the use of AFFF.
The settlement also acknowledges the substantial progress made under the Company's 2019 Consent Order with the State (the "Consent Order"). Since 2019, Chemours has made substantial investments to significantly reduce PFAS emissions from Fayetteville Works and mitigate off-site impacts in the surrounding communities. The agreement recognizes that several Consent Order provisions have been completed and establishes procedures to address certain remaining obligations relating to off-site areas, including implementation of drinking water programs.
The terms of the Settlement, including a further description of claims released and not released, are set forth in the Settlement Agreement, which remains subject to entry of dismissals of the covered litigations.
Consistent with the January 2021 Memorandum of Understanding ("MOU") between the Company, DuPont, and Corteva, Chemours will be responsible for
In addition, all future contributions to the MOU escrow account will be considered satisfied, including Chemours'
This settlement marks further progress under the Strengthening the Long-Term Pillar of Chemours' Pathway to Thrive strategy and ongoing efforts to address legacy liabilities and community concerns. The agreement provides greater clarity regarding the liabilities associated with these matters, acknowledges the significant progress already made at Fayetteville Works, and supports the Company's continued operation of this important manufacturing facility.
About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about expected performance and impact of the cost-sharing arrangements by and between Chemours, Corteva and DuPont related to future eligible PFAS liabilities. Factors that could cause or contribute to these differences include, but are not limited to: the relevant courts' entry of dismissals required for the Settlement Agreement to become final; the outcome of any pending or future litigation related to PFAS or PFOA, including claims by North Carolina subdivisions not covered by the settlement, personal injury claims, property damage claims, and natural resource damages claims; the extent and cost of ongoing remediation obligations and potential future remediation obligations, including performance of remaining obligations under the Consent Order; changes in laws and regulations applicable to PFAS chemicals; the performance by each of the parties of their respective obligations under the MOU. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Further lists and descriptions of risks and uncertainties can be found in Chemours' annual report on Form 10-K for the year ended December 31, 2025 and subsequent reports on Form 10-Q and Form 8-K, the contents of which are not incorporated by reference into, nor do they form part of, this announcement. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Chemours' consolidated financial condition, results of operations, credit rating or liquidity. Chemours does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
INVESTORS
Brandon Ontjes
Vice President, Head of Strategy & Investor Relations
+1.302.773.3309
[email protected]
NEWS MEDIA
Jess Loizeaux
Communications Leader, External Affairs
+1.302.685.8554
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/chemours-dupont-and-corteva-reach-agreement-to-resolve-pfas-related-claims-in-north-carolina-302875109.html
FAQ
How are settlement payments allocated among Chemours, DuPont and Corteva?
Under the January 2021 Memorandum of Understanding, Chemours is responsible for 50% of the $455 million settlement payments, while DuPont and Corteva together are responsible for the remaining 50%. The companies have also agreed on how to value this and potential future multi‑year settlements on a net present value basis for calculating qualified spend.
When do settlement payments begin, and what conditions remain?
Payments are scheduled over 15 years, beginning within 30 days of the execution date of the agreement. The settlement remains subject to the entry of dismissals of the covered litigations, as described in the Settlement Agreement.
How does the settlement relate to Chemours’ 2019 Consent Order for Fayetteville Works?
The settlement acknowledges substantial progress under the 2019 Consent Order, including significant reductions in PFAS emissions and mitigation of off‑site impacts. It recognizes that several Consent Order provisions have been completed and sets procedures to address remaining off‑site obligations, including implementation of drinking water programs.